hh

Projects

SL.NOPROJECT TITLESTATUS
1A Hospital-Based Multi centre Registry for common medical retinal diseases
The aim is to develop a multi centre registry in order to facilitate future RCTs in common medical retinal diseases amenable to treatment with biologics like antiVEGF. Such a registry will facilitate recruitment by matching potential participants interested in research with approved clinical studies using study entry criteria taken from patient visiting OPD safter obtaining their informed consent.
Ongoing
(02-08-2021 till date)
2Knowledge and Perception of Healthcare Professionals Towards Clinical Trial in India
The aim of study is to identify knowledge of perception of health care professional which include doctors, surgeons, Lab technicians, optometrist, nurses and pharmacist towards clinical trials in India. It’s a Pan India cross sectional “e-questionaries” based survey which cover health care profession from South, East, West North and Central region government and private hospitals in India. This study planned to conduct 4 month of data collection and question will be administered via goggle doc form. After giving e-consent will entered into survey question. This survey question consist previously validated 15 knowledge and 5 perception based question. This survey will provide an overall perception and aspect about the Clinical Trials from the different geographical areas of India from the view point of healthcare professionals.

Survey Link

Ongoing
(01-04-2022 till date)
3Knowledge and awareness of trial participants about clinical trial in India – A multicentric study
This is a cross sectional survey of participants who have been involved in clinical trials on research in the past or currently a part of any trials in various departments at clinical trial sites.
Ongoing
(01-04-2022 till date)
4Attitude and perception of patients and their bystanders towards clinical trials in India- A multicentric cross sectional survey
This multicentric, cross sectional survey shall be conducted among patients and their bystanders aged 18 years and above at six clinical trial sites.
Ongoing
(01-04-2022 till date)